Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer
- 1 January 1993
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (4) , 492-497
- https://doi.org/10.1016/s0959-8049(05)80137-6
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Effect of Tamoxifen on Serum Insulinlike Growth Factor I Levels in Stage I Breast Cancer PatientsJNCI Journal of the National Cancer Institute, 1990
- Diffusion of insulin-like growth factor 1 in human breast cancer explantsCancer Letters, 1990
- The insulin-like growth factor binding protein BP-25 is expressed by human breast cancer cellsBiochemical and Biophysical Research Communications, 1989
- Failure of acid–ethanol treatment to prevent interference by binding proteins in radioligand assays for the insulin-like growth factorsJournal of Endocrinology, 1988
- Presence and characterization of insulin-like growth factor 1 receptors in human benign breast diseaseEuropean Journal of Cancer and Clinical Oncology, 1988
- Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding protein in human breast cancer cell linesBiochemical and Biophysical Research Communications, 1988
- Partial characterization of somatomedin C-like immunoreactivity secreted by breast cancer cells in vitroMolecular and Cellular Endocrinology, 1987
- Elevated bioactive prolactin in women at risk for familial breast cancerEuropean Journal of Cancer and Clinical Oncology, 1985
- Elevated Growth Hormone Levels in Sera from Breast Cancer PatientsHormone and Metabolic Research, 1985
- Estimation of Somatomedin-C Levels in Normals and Patients with Pituitary Disease by RadioimmunoassayJournal of Clinical Investigation, 1977